Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilide

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 3 40-3, 1996, Pages

  Grover, Gary J ^a   D'Alonzo, Albert J ^a   Dzwonczyk, Steven ^a   Parham, Charles S ^a   Darbenzio, Raymond B ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

class III antiarrhythmic agent; myocardial ischemia

Indexed keywords

ANTIARRHYTHMIC AGENT; DOFETILIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; DOG; DOSE RESPONSE; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029794081     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.3.h1207     Document Type: Article

References (31)

1. Atwal, K. S., G. J. Grover, S. Ahmed, F. N. Ferrara, T. W. Harper, K. S. Kim, P. G. Sleph, S. Dzwonczyk, A. D. Russell, S. Moreland, J. R. McCullough, and D. E. Normandin. Cardioselective anti-ischemic ATP-sensitive potassium channel openers. J. Med. Chem. 36: 3971-3974, 1993.
2. ATP channels and ischemic preconditioning in dogs. Am. J. Physiol. 264 (Heart Circ. Physiol 33): H1327-H1336, 1993.
3. 1-adrenergic mechanism. Circ. Res. 73: 656-670, 1993.
4. Cole, W. C., C. D. McPherson, and D. Sontag. ATP-regulated channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 69: 571-581, 1991.
5. D'Alonzo, A. J., R. B. Darbenzio, C. S. Parham, and G. J. Grover. Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovasc. Res. 26: 1046-1053, 1992.
6. Downey, J. M., G. S. Liu, and J. D. Thornton. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc. Res. 27: 3-8, 1993.
7. Ferdinandy, P., Z. Szilvassy, M. Koltai, and L. Dux. Ventricular overdrive pacing-induced preconditioning and no-flow ischemia-induced preconditioning in isolated working rat hearts. J. Cardiovasc. Pharmacol. 25: 97-104, 1995.
8. Galiñanes, M., M. J. Shattock, and D. J. Hearse. Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia. Cardiovasc. Res. 6: 1063-1068, 1992.
9. Gross, G. J., and J. A. Auchampach. Blockade of ATP-sensitive potassium channel prevents myocardial preconditioning in dogs. Circ. Res. 70: 223-239, 1992.
10. Grover, G. J. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J. Cardiovasc. Pharmacol. 24, Suppl. 4: S18-S27, 1994.
11. Grover, G. J., A. J. D'Alonzo, T. A. Hess, P. G. Sleph, and R. B. Darbenzio. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening in guinea pig hearts. Cardiouasc. Res. 30: 731-738, 1995.
12. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J. Cardiovasc. Pharmacol. 26: 145-152, 1995.
13. Grover, G. J., S. Dzwonczyk, C. S. Parham, and P. G. Sleph. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc. Drugs Ther. 4: 465-474, 1990.
14. Grover, G. J., J. R. McCullough, A. J. D'Alonzo, C. A. Sargent, and K. S. Atwal. Cardioprotective profile of the cardiac-sensitive potassium channel opener BMS-180448. J. Cardiovasc. Pharmacol. 25: 40-50, 1995.
15. 1-receptors. Circulation 86: 1310-1316, 1992.
16. - current by dofetilide. Circ. Res. 72: 75-83, 1993.
17. - channels to AI receptors by G proteins in rat ventricular myocytes. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H820-H826, 1990.
18. Ohta, H., Y. Jinno, K. Ogawa, N. Fukushima, and J. Nishikore. Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart. Eur. J. Pharmacol. 204: 171-177, 1991.
19. - channel from rat liver and beef heart mitochondria. J. Biol. Chem. 36: 26062-26069, 1992.
20. Sargent, C. A., M. A. Smith, S. Dzwonczyk, P. G. Sleph, and G. J. Grover. Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents. J. Pharmacol. Exp. Ther. 259: 97-103, 1991.
21. Schulz, R., J. Rose, and G. Heusch. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am. J. Physiol. 267 (Heart Circ. Physiol. 36):H1341-H1352, 1994.
22. + channels in early phase of reperfusion and its protective role against myocardial stunning. Circulation 92: 2266-2270, 1995.
23. Speechly-Dick, M. E., G. J. Grover, and D. M. Yellon. Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent potassium channel? Studies of contractile function in an in vitro model. Circ. Res. 77: 1030-1035, 1995.
24. Tan, H. L., P. Mazon, H. J. Verberne, M. E. Sleeswijk, R. Coronel, T. Opthof, and M. J. Janse. Ischemic preconditioning delays ischemia induced cellular uncoupling in rabbit myocardium by activation of ATP-sensitive potassium channels. Cardiovasc. Res. 27: 644-651, 1993.
25. Toombs, C. F., D. S. McGee, W. E. Johnston, and J. Vinten-Johansen. Protection from ischaemic-reperfusion injury with adenosine treatment is reversed by inhibition of ATP-sensitive potassium channels. Cardiovasc. Res. 27: 623-629, 1993.
26. Tweedie, D., C. Henderson, and K. Kane. Glibenclamide, but not class III drugs, prevents ischemic shortening of the refractory period in guinea pig hearts. Eur. J. Pharmacol. 24: 251-257, 1993.
27. ATP channel. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H829-H839, 1994.
28. Waldo, A. L., A. J. Camm, H. de Ruyter, P. L. Friedman, D. J. MacNell, B. Pitt, C. M. Pratt, P. J. Schwartz, E. P. Veltri, and SWORD Investigators. Preliminary mortality results from the survival with oral d-sotalol (SWORD) trial (Abstract). J Am. Col. Cardiol. 25: 15A, 1995.
29. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs Circulation 89: 1769-1775, 1994.
30. Ytrehus, K., Y., Liu, and J. M. Downey. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Phvsiol. 266 (Heart Circ. Physiol. 35): H1145-H1152, 1994.
31. Zuanetti, G., and P. B. Corr. Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping. J. Pharmacol. Exp. Ther. 256: 325-334, 1991.